Stock Events

Stock Events

Acura Pharmaceuticals 

$0.01
14
+$0+0% Monday 20:00

Statistics

Day High
0
Day Low
0
52W High
0.02
52W Low
0
Volume
400
Avg. Volume
1,261
Mkt Cap
660,020
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

11JanExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q4 2022
-0.18
-0.12
-0.06
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-56.24%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
3.13MRevenue
-1.76MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACUR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical sector, directly competing with Acura in drug development and commercialization.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Acura Pharmaceuticals in the development and marketing of medications.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a leading pharmaceutical company that competes in the same therapeutic areas as Acura.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company that competes with Acura in developing innovative therapies.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company, competing with Acura in the discovery, development, and commercialization of drugs.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Acura Pharmaceuticals in research, development, manufacturing, and marketing of pharmaceuticals.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that competes with Acura in the pharmaceutical and healthcare sector, including the development of new medicines.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global pharmaceutical company that competes with Acura Pharmaceuticals in the development and marketing of therapeutic solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Acura in the pharmaceutical market.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Acura Pharmaceuticals in developing and commercializing prescription medicines.

About

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.
Show more...
CEO
Mr. Robert B. Jones
Employees
9
Country
US
ISIN
US00509L8028

Listings

OTC Link
US
ACUR

0 Comments

Share your thoughts

FAQ

What is Acura Pharmaceuticals stock price today?▼
The current price of ACUR is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Acura Pharmaceuticals stock price performance more closely on the chart.
What is Acura Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Acura Pharmaceuticals stocks are traded under the ticker ACUR.
Is Acura Pharmaceuticals stock price growing?▼
ACUR stock has risen by +0% compared to the previous week, the month change is a +1,900% rise, over the last year Acura Pharmaceuticals has showed a -49.49% decrease.
What is Acura Pharmaceuticals market cap?▼
Today Acura Pharmaceuticals has the market capitalization of 660,020
What is Acura Pharmaceuticals revenue for the last year?▼
Acura Pharmaceuticals revenue for the last year amounts to 3.13M USD.
What is Acura Pharmaceuticals net income for the last year?▼
ACUR net income for the last year is -1.76M USD.
How many employees does Acura Pharmaceuticals have?▼
As of April 02, 2026, the company has 9 employees.
In which sector is Acura Pharmaceuticals located?▼
Acura Pharmaceuticals operates in the Health Care sector.
When did Acura Pharmaceuticals complete a stock split?▼
The last stock split for Acura Pharmaceuticals was on August 28, 2015 with a ratio of 1:5.
Where is Acura Pharmaceuticals headquartered?▼
Acura Pharmaceuticals is headquartered in Palatine, US.